Myriad Genetics Q2 Revenue USD 190.7 Million Vs. IBES Estimate USD 206 Million
MYGN•Q2 revenue and margin update
Jul 30 (Reuters) - Myriad Genetics Q2 gross margin 66.6%.
- Q2 adjusted operating expenses USD 150.5 million
- Q2 operating expenses USD 165.9 million
- Q2 operating income USD -38.9 million
